Cita APA (7a ed.)
Casares-Lagar, N., Arribillaga, L., Sarobe, P., Dotor, J., Lopez-Diaz-de-Cerio, A., Melero, I., & Lasarte-Sagastibelza, J. (2003). CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. American Association of Immunologists.
Cita Chicago Style (17a ed.)
Casares-Lagar, N.|||/items/32524a9b-f393-47ee-bf77-0737c65e0b7b, L.|||/items/a1a55d50-66c3-4216-9968-07b0c7f976cc Arribillaga, P.|||/items/e6f6a7ac-cfe2-409e-ab14-057dea5fd160 Sarobe, J.|||/items/6606b7a3-73b7-49d9-bc1b-c565b3e1c208 Dotor, A.|||/items/29ab6acb-fcbb-43ff-b4c1-e2dc95e22bcb Lopez-Diaz-de-Cerio, I.|||/items/82113ea8-7ce1-49d5-9ee3-42cf20db1c4e Melero, y J.J.|||/items/e366ad83-3db4-41ec-a9da-ed9159ba5c0c Lasarte-Sagastibelza. CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-primed CD4+ T Cells with IFN-gamma-dependent Antiangiogenic Activity, as Well as Long-lasting Tumor Immunity Elicited by Peptide Vaccination. American Association of Immunologists, 2003.
Cita MLA (9a ed.)
Casares-Lagar, N.|||/items/32524a9b-f393-47ee-bf77-0737c65e0b7b, et al. CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-primed CD4+ T Cells with IFN-gamma-dependent Antiangiogenic Activity, as Well as Long-lasting Tumor Immunity Elicited by Peptide Vaccination. American Association of Immunologists, 2003.
Precaución: Estas citas no son 100% exactas.